Errntknght
Registered User
Clearly the Suns team is full of question marks at this point. Which of them do you feel are the most significant?
Markieff Morris stands out to me. I'm certainly glad we got Teletovic and Leuer so he should get the message that he could wind up sitting if he doesn't produce. Chandler echoes the same because with two viable C's he is not likely to slide over to that position nearly as much. I hope the team is ready to dump him if he proves to be a cancer - the odds of that seem 'promising' to me. He's even a question mark on the floor - the Markieff we saw last year was not nearly as productive as the one that took the ball to the hoop the year before - and got the line twice as much. Last year was a career low in rebounding, too.
Ronnie Price is another big one for me. His stats don't suggest that he runs the fastbreak - 1.6 FTA per 36 says that he rarely attacks the rim under any conditions. His assist to TO ratio was good last year at 3.2 but for his career its 2.0, right down there with Bled and Knight. Why we didin't re-sign Ish Smith is beyond me - he's better than Price is every category except 3 pt shooting. (He's better at that too if you leave out his disastrous year shooting them for us.) Price doesn't figure to play much, of course, but if Bled or Knight is injured we'll be scrambling to pick up another PG - or combo guard.
Teletovic's health. Every players health is always a question but Mirza is coming off a very serious problem.
Chandler and Len's health. If Len is a little more robust than last year and Tyson has an average year (65 games @ 29 min per) they'll come close to covering the C slot 90% of the time. If anything untoward happens to either of them we'll be watching a lot of small ball.
Will Hornacek find a way to get production out out of TJ? We all know that TJ can score inside the arc but its far from clear how his game fits with the teams offense. I'd seriously toy with the idea of starting him, hoping that would encourage our 'PGs' to look for him - that doesn't sound like Jeff though.
Markieff Morris stands out to me. I'm certainly glad we got Teletovic and Leuer so he should get the message that he could wind up sitting if he doesn't produce. Chandler echoes the same because with two viable C's he is not likely to slide over to that position nearly as much. I hope the team is ready to dump him if he proves to be a cancer - the odds of that seem 'promising' to me. He's even a question mark on the floor - the Markieff we saw last year was not nearly as productive as the one that took the ball to the hoop the year before - and got the line twice as much. Last year was a career low in rebounding, too.
Ronnie Price is another big one for me. His stats don't suggest that he runs the fastbreak - 1.6 FTA per 36 says that he rarely attacks the rim under any conditions. His assist to TO ratio was good last year at 3.2 but for his career its 2.0, right down there with Bled and Knight. Why we didin't re-sign Ish Smith is beyond me - he's better than Price is every category except 3 pt shooting. (He's better at that too if you leave out his disastrous year shooting them for us.) Price doesn't figure to play much, of course, but if Bled or Knight is injured we'll be scrambling to pick up another PG - or combo guard.
Teletovic's health. Every players health is always a question but Mirza is coming off a very serious problem.
Chandler and Len's health. If Len is a little more robust than last year and Tyson has an average year (65 games @ 29 min per) they'll come close to covering the C slot 90% of the time. If anything untoward happens to either of them we'll be watching a lot of small ball.
Will Hornacek find a way to get production out out of TJ? We all know that TJ can score inside the arc but its far from clear how his game fits with the teams offense. I'd seriously toy with the idea of starting him, hoping that would encourage our 'PGs' to look for him - that doesn't sound like Jeff though.
